DELEK GP SP.ADR/1/01/O.N Cash Flow Conversion Efficiency
DELEK GP SP.ADR/1/01/O.N cash flow conversion efficiency. Based on the latest financial reports, DELEK GP SP.ADR/1/01/O.N (6D40) has a cash flow conversion efficiency ratio of 0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€63.00 Million ≈ $73.65 Million USD) by net assets (€16.48 Billion ≈ $19.27 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of DELEK GP SP.ADR/1/01/O.N (2021–2025)
Cash flow conversion efficiency of DELEK GP SP.ADR/1/01/O.N from 2021 to 2025. This chart illustrates how DELEK GP SP.ADR/1/01/O.N's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 6D40 share price today for real-time trading data and today's change.
DELEK GP SP.ADR/1/01/O.N Cash Flow Conversion Ratio Explained
DELEK GP SP.ADR/1/01/O.N cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
DELEK GP SP.ADR/1/01/O.N Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DELEK GP SP.ADR/1/01/O.N ranked by their cash flow conversion efficiency. Also see how much is DELEK GP SP.ADR/1/01/O.N worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FLSmidth & Co.
CO:FLS
|
0.010x |
|
Colliers International Group Inc Bats
TO:CIGI
|
0.044x |
|
PERSIMMON UNSPON. ADR 2
F:OHP0
|
N/A |
|
Shenzhen Salubris Pharmaceuticals Co Ltd
SHE:002294
|
0.045x |
|
Samsung Securities
KO:016360
|
-0.260x |
|
Sichuan Em Technology Co Ltd
SHG:601208
|
-0.017x |
|
Petronas Dagangan Bhd
KLSE:5681
|
0.169x |
|
CSW Industrials, Inc.
NASDAQ:CSW
|
0.054x |
Annual Cash Flow Conversion Efficiency for DELEK GP SP.ADR/1/01/O.N (2021–2025)
The table below shows the annual cash flow conversion efficiency of DELEK GP SP.ADR/1/01/O.N from 2021 to 2025. Review free cash flow generation of DELEK GP SP.ADR/1/01/O.N to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €17.25 Billion ≈ $20.17 Billion |
€2.71 Billion ≈ $3.17 Billion |
0.157x | +70.49% |
| 2024-12-31 | €18.54 Billion ≈ $21.68 Billion |
€1.71 Billion ≈ $2.00 Billion |
0.092x | -24.60% |
| 2023-12-31 | €14.94 Billion ≈ $17.46 Billion |
€1.83 Billion ≈ $2.14 Billion |
0.122x | -76.93% |
| 2022-12-31 | €12.88 Billion ≈ $15.06 Billion |
€6.83 Billion ≈ $7.98 Billion |
0.530x | -21.68% |
| 2021-12-31 | €5.19 Billion ≈ $6.07 Billion |
€3.51 Billion ≈ $4.11 Billion |
0.677x | -- |
About DELEK GP SP.ADR/1/01/O.N
Delek Group Ltd., an energy company, engages in the exploration, development, production, and marketing of oil and natural gas in Israel and internationally. It holds interests in the Leviathan and Aphrodite reservoirs in Cyprus; assets oil offshore oil assets in the Mediterranean, as well as oil and gas reserves in the North Sea region; and treatment, and storage facilities. Delek Group Ltd. was… Read more